Natco Pharma gets nod for generic Everolimus tablets
The approval is for the Abbreviated New Drug Application (ANDA) for Everolimus tablets for oral suspension (TFOS) of ...
Daily8d
Natco Pharma gets approval for Everolimus tablets for Oral Suspension for subependymal giant cell astrocytoma
Hyderabad: NATCO Pharma Limited, an Indian pharmaceutical company, has announced the approval of its Abbreviated New Drug ...
Surgeons At Doylestown Health Successfully Implant Dissolvable Stent
The team from Doylestown Health's Vascular Surgery is the first in the greater Philadelphia region to use the Abbott ...
Morningstar9d
Breckenridge announces final FDA approval for Everolimus tablets for oral suspension, AB-rated to AFINITOR DISPERZ®
announced today that the Food and Drug Administration (FDA) has granted final approval of Everolimus Tablets for Oral Suspension (TFOS), 2mg, 3mg and 5mg, a generic version of AFINITOR DISPERZ ...
money.rediff8d
Natco Pharma Gets US FDA Approval for Generic Everolimus Tablets
Natco Pharma has received US FDA approval for its generic version of Everolimus tablets for oral suspension, indicated for ...
Medscape11d
Drug Combo for Common Neuroendocrine Tumor: A New Standard?
Adding lanreotide to everolimus significantly prolonged progression-free survival compared with everolimus alone in patients ...
U.S. FDA nod for Natco Pharma’s generic of Novartis drug
Natco Pharma receives FDA approval for Everolimus tablets, launching generic version of Afinitor Disperz in U.S. market.
Yahoo Finance9d
Breckenridge announces final FDA approval for Everolimus tablets for oral suspension, AB-rated to AFINITOR DISPERZ®
Everolimus TFOS is a kinase inhibitor indicated in adult and pediatric patients aged one year and older with tuberous sclerosis complex ("TSC") for the treatment of subependymal giant cell ...